data_1ccn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ccn _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.486 1.353 1 N-CA-C 126.642 5.793 . . . . 0.0 126.642 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.7 p -90.15 76.16 6.94 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 111.902 -2.408 . . . . 0.0 110.593 -172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.8 m -83.19 112.08 19.52 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 111.659 -2.519 . . . . 0.0 111.431 -171.156 -51.999 -65.846 -85.068 103.778 2.047 99.455 -56.551 -69.068 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 32.8 m -107.66 145.96 32.4 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.98 -78.484 -58.23 105.73 104.573 2.031 103.61 -138.419 -62.316 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -74.5 -40.66 1.03 Allowed 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 121.367 1.378 . . . . 0.0 114.279 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 91.2 p -121.55 157.62 30.32 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.351 0.978 . . . . 0.0 111.494 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.77 -33.52 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.767 1.227 . . . . 0.0 109.779 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -70.84 -44.21 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.22 79.69 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.617 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.84 -44.6 76.79 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.762 0.664 . . . . 0.0 110.747 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 p -62.85 -39.45 94.41 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -63.87 -40.28 96.18 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 123.908 0.883 . . . . 0.0 112.171 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -56.89 -46.41 81.92 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.04 1.736 . . . . 0.0 109.466 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -67.95 -33.73 75.23 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.904 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.1 t -68.78 -46.65 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 CA-C-O 116.775 -1.583 . . . . 0.0 107.036 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.9 t -49.92 -33.56 17.76 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 120.243 1.383 . . . . 0.0 111.934 170.081 173.24 -89.279 -79.751 100.12 2.049 105.598 -39.452 -55.021 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.83 9.75 42.75 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 117.042 -1.456 . . . . 0.0 111.95 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.8 mt -56.63 -39.31 76.87 Favored Pre-proline 0 N--CA 1.487 1.378 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 169.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.38 -15.75 51.39 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 C-N-CA 122.573 2.182 . . . . 0.0 114.996 169.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.26 32.0 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.171 0.891 . . . . 0.0 111.609 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.309 2.5 m -140.28 -76.05 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -87.09 73.76 2.9 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 CA-C-N 121.811 1.682 . . . . 0.0 113.416 -151.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -54.46 -45.41 73.13 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.551 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.25 -34.78 76.83 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -72.76 -40.7 65.79 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.769 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m -52.48 -42.27 64.08 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 116.66 -1.638 . . . . 0.0 111.126 165.516 -55.021 -39.452 -79.751 105.598 2.049 100.12 -89.279 173.24 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . 0.32 . . -54.87 -53.78 51.04 Favored 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 119.563 3.171 . . . . 0.0 119.563 168.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.7 p -65.7 -46.73 77.92 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 124.753 1.283 . . . . 0.0 109.577 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.251 23.2 m-85 -66.76 -29.47 69.44 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 124.727 1.211 . . . . 0.0 112.893 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.5 p -116.63 12.0 14.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.14 44.17 97.63 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 124.235 0.922 . . . . 0.0 114.179 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 71.3 m -112.75 159.89 18.5 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 -177.892 -62.316 -138.419 105.73 103.61 2.031 104.573 -58.23 -78.484 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.9 pt -119.53 114.93 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-N 112.633 -2.076 . . . . 0.0 111.945 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.7 mt -85.99 105.26 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.86 134.15 21.05 Favored Pre-proline 0 N--CA 1.495 1.819 0 C-N-CA 123.469 0.707 . . . . 0.0 112.125 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -50.11 -30.13 24.27 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 124.367 3.378 . . . . 0.0 115.944 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.68 132.77 40.01 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-N 112.898 -1.956 . . . . 0.0 112.406 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.39 -7.99 16.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 127.331 2.252 . . . . 0.0 114.719 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 t -150.37 167.75 26.15 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 125.385 1.474 . . . . 0.0 109.234 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.6 m -101.35 140.89 21.64 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 112.622 -2.081 . . . . 0.0 113.244 -168.968 -69.068 -56.551 -85.068 99.455 2.047 103.778 -65.846 -51.999 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.97 151.15 16.67 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 124.922 3.748 . . . . 0.0 109.449 171.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.75 -35.57 47.02 Favored Glycine 0 CA--C 1.545 1.936 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.812 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -89.87 -5.52 56.74 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -127.59 30.59 5.31 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.131 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.95 102.38 11.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.9 m120 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 116.8 -1.571 . . . . 0.0 113.489 -178.823 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.486 1.353 1 N-CA-C 126.642 5.793 . . . . 0.0 126.642 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.575 HG22 HG12 ' A' ' 34' ' ' ILE . 67.7 p -90.15 76.16 6.94 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 111.902 -2.408 . . . . 0.0 110.593 -172.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 37.8 m -83.19 112.08 19.52 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 111.659 -2.519 . . . . 0.0 111.431 -171.156 -51.999 -65.846 -85.068 103.778 2.047 99.455 -56.551 -69.068 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 32.8 m -107.66 145.96 32.4 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.98 -78.484 -58.23 105.73 104.573 2.031 103.61 -138.419 -62.316 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -74.5 -40.66 1.03 Allowed 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 121.367 1.378 . . . . 0.0 114.279 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 91.2 p -121.55 157.62 30.32 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.351 0.978 . . . . 0.0 111.494 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.77 -33.52 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.767 1.227 . . . . 0.0 109.779 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -70.84 -44.21 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.22 79.69 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.617 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.84 -44.6 76.79 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.762 0.664 . . . . 0.0 110.747 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 p -62.85 -39.45 94.41 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -63.87 -40.28 96.18 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 123.908 0.883 . . . . 0.0 112.171 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -56.89 -46.41 81.92 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.04 1.736 . . . . 0.0 109.466 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -67.95 -33.73 75.23 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.904 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.1 t -68.78 -46.65 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 CA-C-O 116.775 -1.583 . . . . 0.0 107.036 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.9 t -49.92 -33.56 17.76 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 120.243 1.383 . . . . 0.0 111.934 170.081 173.24 -89.279 -79.751 100.12 2.049 105.598 -39.452 -55.021 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.83 9.75 42.75 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 117.042 -1.456 . . . . 0.0 111.95 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.41 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 52.8 mt -56.63 -39.31 76.87 Favored Pre-proline 0 N--CA 1.487 1.378 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 169.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.9 Cg_endo -64.38 -15.75 51.39 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 C-N-CA 122.573 2.182 . . . . 0.0 114.996 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.26 32.0 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.171 0.891 . . . . 0.0 111.609 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.485 ' HB ' ' HD3' ' A' ' 22' ' ' PRO 0.309 2.5 m -140.28 -76.05 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.548 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 62.0 Cg_endo -87.09 73.76 2.9 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 CA-C-N 121.811 1.682 . . . . 0.0 113.416 -151.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -54.46 -45.41 73.13 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.551 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.25 -34.78 76.83 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 96.3 mt -72.76 -40.7 65.79 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.769 174.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m -52.48 -42.27 64.08 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 116.66 -1.638 . . . . 0.0 111.126 165.516 -55.021 -39.452 -79.751 105.598 2.049 100.12 -89.279 173.24 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . 0.32 . . -54.87 -53.78 51.04 Favored 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 119.563 3.171 . . . . 0.0 119.563 168.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.7 p -65.7 -46.73 77.92 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 124.753 1.283 . . . . 0.0 109.577 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.251 23.2 m-85 -66.76 -29.47 69.44 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 124.727 1.211 . . . . 0.0 112.893 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.5 p -116.63 12.0 14.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.14 44.17 97.63 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 124.235 0.922 . . . . 0.0 114.179 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 71.3 m -112.75 159.89 18.5 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 -177.892 -62.316 -138.419 105.73 103.61 2.031 104.573 -58.23 -78.484 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.481 HG12 ' CD2' ' A' ' 44' ' ' TYR . 41.9 pt -119.53 114.93 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-N 112.633 -2.076 . . . . 0.0 111.945 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.575 HG12 HG22 ' A' ' 2' ' ' THR . 31.7 mt -85.99 105.26 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -110.86 134.15 21.05 Favored Pre-proline 0 N--CA 1.495 1.819 0 C-N-CA 123.469 0.707 . . . . 0.0 112.125 -174.07 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 69.3 Cg_exo -50.11 -30.13 24.27 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 124.367 3.378 . . . . 0.0 115.944 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.68 132.77 40.01 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-N 112.898 -1.956 . . . . 0.0 112.406 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.39 -7.99 16.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 127.331 2.252 . . . . 0.0 114.719 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 t -150.37 167.75 26.15 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 125.385 1.474 . . . . 0.0 109.234 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.6 m -101.35 140.89 21.64 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 112.622 -2.081 . . . . 0.0 113.244 -168.968 -69.068 -56.551 -85.068 99.455 2.047 103.778 -65.846 -51.999 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.97 151.15 16.67 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 124.922 3.748 . . . . 0.0 109.449 171.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.75 -35.57 47.02 Favored Glycine 0 CA--C 1.545 1.936 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.812 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -89.87 -5.52 56.74 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.481 ' CD2' HG12 ' A' ' 33' ' ' ILE . 13.5 m-85 -127.59 30.59 5.31 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.131 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.95 102.38 11.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.9 m120 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 116.8 -1.571 . . . . 0.0 113.489 -178.823 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.486 1.353 1 N-CA-C 126.642 5.793 . . . . 0.0 126.642 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.575 HG22 HG12 ' A' ' 34' ' ' ILE . 67.7 p -90.15 76.16 6.94 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 111.902 -2.408 . . . . 0.0 110.593 -172.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 37.8 m -83.19 112.08 19.52 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 111.659 -2.519 . . . . 0.0 111.431 -171.156 -51.999 -65.846 -85.068 103.778 2.047 99.455 -56.551 -69.068 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 32.8 m -107.66 145.96 32.4 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.98 -78.484 -58.23 105.73 104.573 2.031 103.61 -138.419 -62.316 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -74.5 -40.66 1.03 Allowed 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 121.367 1.378 . . . . 0.0 114.279 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 91.2 p -121.55 157.62 30.32 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.351 0.978 . . . . 0.0 111.494 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.77 -33.52 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.767 1.227 . . . . 0.0 109.779 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -70.84 -44.21 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.22 79.69 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.617 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.84 -44.6 76.79 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.762 0.664 . . . . 0.0 110.747 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 p -62.85 -39.45 94.41 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -63.87 -40.28 96.18 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 123.908 0.883 . . . . 0.0 112.171 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -56.89 -46.41 81.92 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.04 1.736 . . . . 0.0 109.466 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -67.95 -33.73 75.23 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.904 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.1 t -68.78 -46.65 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 CA-C-O 116.775 -1.583 . . . . 0.0 107.036 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.9 t -49.92 -33.56 17.76 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 120.243 1.383 . . . . 0.0 111.934 170.081 173.24 -89.279 -79.751 100.12 2.049 105.598 -39.452 -55.021 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.83 9.75 42.75 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 117.042 -1.456 . . . . 0.0 111.95 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.41 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 52.8 mt -56.63 -39.31 76.87 Favored Pre-proline 0 N--CA 1.487 1.378 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 169.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.9 Cg_endo -64.38 -15.75 51.39 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 C-N-CA 122.573 2.182 . . . . 0.0 114.996 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.26 32.0 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.171 0.891 . . . . 0.0 111.609 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.485 ' HB ' ' HD3' ' A' ' 22' ' ' PRO 0.309 2.5 m -140.28 -76.05 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.548 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 62.0 Cg_endo -87.09 73.76 2.9 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 CA-C-N 121.811 1.682 . . . . 0.0 113.416 -151.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -54.46 -45.41 73.13 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.551 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.25 -34.78 76.83 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 96.3 mt -72.76 -40.7 65.79 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.769 174.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m -52.48 -42.27 64.08 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 116.66 -1.638 . . . . 0.0 111.126 165.516 -55.021 -39.452 -79.751 105.598 2.049 100.12 -89.279 173.24 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . 0.32 . . -54.87 -53.78 51.04 Favored 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 119.563 3.171 . . . . 0.0 119.563 168.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.7 p -65.7 -46.73 77.92 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 124.753 1.283 . . . . 0.0 109.577 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.251 23.2 m-85 -66.76 -29.47 69.44 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 124.727 1.211 . . . . 0.0 112.893 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.5 p -116.63 12.0 14.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.14 44.17 97.63 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 124.235 0.922 . . . . 0.0 114.179 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 71.3 m -112.75 159.89 18.5 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 -177.892 -62.316 -138.419 105.73 103.61 2.031 104.573 -58.23 -78.484 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.481 HG12 ' CD2' ' A' ' 44' ' ' TYR . 41.9 pt -119.53 114.93 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-N 112.633 -2.076 . . . . 0.0 111.945 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.575 HG12 HG22 ' A' ' 2' ' ' THR . 31.7 mt -85.99 105.26 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -110.86 134.15 21.05 Favored Pre-proline 0 N--CA 1.495 1.819 0 C-N-CA 123.469 0.707 . . . . 0.0 112.125 -174.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 69.3 Cg_exo -50.11 -30.13 24.27 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 124.367 3.378 . . . . 0.0 115.944 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.68 132.77 40.01 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-N 112.898 -1.956 . . . . 0.0 112.406 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.39 -7.99 16.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 127.331 2.252 . . . . 0.0 114.719 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 t -150.37 167.75 26.15 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 125.385 1.474 . . . . 0.0 109.234 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.6 m -101.35 140.89 21.64 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 112.622 -2.081 . . . . 0.0 113.244 -168.968 -69.068 -56.551 -85.068 99.455 2.047 103.778 -65.846 -51.999 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.97 151.15 16.67 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 124.922 3.748 . . . . 0.0 109.449 171.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.75 -35.57 47.02 Favored Glycine 0 CA--C 1.545 1.936 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.812 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -89.87 -5.52 56.74 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.481 ' CD2' HG12 ' A' ' 33' ' ' ILE . 13.5 m-85 -127.59 30.59 5.31 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.131 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.95 102.38 11.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.9 m120 . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 116.8 -1.571 . . . . 0.0 113.489 -178.823 . . . . . . . . 0 0 . 1 stop_ save_